Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene therapy for severe hemophilia A.
SustainCERT’s validation gives companies confidence that Regrow can underpin high‑integrity climate claims”— Lucia von ...
Selecting the right technology partner for our future was critical...XEN is that partner.”— Phil Cohen, President of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results